AzTrials
AzTrials

Acute Coronary SyndromeISACS-ARCHIVESNCT04008173

The International Survey of Acute Coronary Syndromes-ARCHIVES

An observational study of Acute Coronary Syndrome and Unstable Angina Pectoris, run by University of Bologna at 1 site in Italy.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

ISACS ARCHIVES network is part of ISACS TC (NCT01218776) health care program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Non-interventional patient registry
How many people
130,000 participants
Where
1 siteItaly
Study dates
28 Jun 2019to 31 Dec 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Subjects admitted with a diagnosis of acute coronary syndromes

Who may be able to join

  • acute coronary syndromes

Who cannot join

  • under age or not able to give informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site
  • University of Bologna

    Bologna, Bologna, 40138

Other trials in Italy

About this study

ISACS ARCHIVES network is part of ISACS TC (NCT01218776) health care program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The ISACS ARCHIVES network assists health care providers, scientists, and policymakers seeking unbiased information about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services, particularly prescription medications and medical devices in acute coronary syndromes (ACS).

Read the detailed description

Purpose

ISACS-TC investigators may deposit to the ISACS ARCHIVES their registry data acquired prior to the first submitted date of ISACS-TC at ClinicalTrials.gov (October 7, 2010). Non- ISACS investigators with ACS data are welcome to deposit their data to the ISACS ARCHIVES as well. In this case the data may have been acquired prior or later than October 7, 2010. The data in the ISACS ARCHIVES will be catalogued and made available to the general research community. The ISACS ARCHIVES will use an established informatics infrastructure, hosted and managed by the ISACS TC (NCT01218776) and the Department of Electrical and Computer Engineering, University of California, Los Angeles, California, which will enable the sharing and use of data. The NIH. Gov. Registration number for the ISACS ARCHIVES will serve as the key for ACS related data submissions to the contact persons.

Applicable Data The ISACS ARCHIVES will accept only de-identified data from human subjects' studies on ACS (for a definition of human subjects see: https://humansubjects.nih.gov/glossary). This will include data from clinical trials, epidemiological surveys, and other types of studies involving human subjects. Databases with significant genomic data (e.g., genome-wide association studies, medical sequencing, molecular diagnostic assays), are expected to be deposited as well. Likewise, physical bio-samples can be included in the ISACS ARCHIVES.

Data Sharing Procedures Data submitted to the ISACS ARCHIVES must be de-identified by the investigator prior to submission. Submitted data will be subjected to algorithms that check for basic data accuracy. Any problematic data items will be summarized in a report and returned to the investigator for corrective action, if necessary, before data are accepted. Data will be made available for sharing with general research community 2 months after the deposit. This 2-month embargo period will provide study investigators with protected time to check for basic data accuracy. After the embargo, the data will be made available for sharing with the general research community. Investigators will be able to gain access to ISACS ARCHIVES data by submitting a data access request to ISACS TC (NCT01218776) contact persons. Data requests will be reviewed by an ISACS ARCHIVES Data Access Committee. The Department of Electrical and Computer Engineering, University of California, Los Angeles, California will collect data.

ISACS Data Archive Sharing The following is a summary of tasks and expectations related to submitting data to the ISACS ARCHIVES. The purpose of this summary is to provide an overview of data submission and data sharing via the ISACS ARCHIVES. This list only provides a summary of tasks.

Investigators are expected to:

  1. Collect Personally Identifiable Information (PII) from research subjects that will allow for the creation of the ISACS ARCHIVES Global Unique Identifier.
  2. Provide a de-identified subject ID, which is required for submission of data to the ISACS ARCHIVES.
  3. Complete and submit a Data-Sharing Agreement and Permission (DSAP) to ISACS TC (NCT01218776) contact persons.
  4. Review the ISACS TC data definition for the measures/experiments expected and define the project's data definition harmonized to that standard.
  5. Work with ISACS TC (NCT01218776) contact persons to define any undefined measures in accordance with ISACS TC practices.
  6. Specify the expected measures to be collected by the project in a summary table to be forwarded to the ISACS TC (NCT01218776) contact persons.
  7. Address any post submission quality assurance and quality control (QA/QC) checks that have been identified by the ISACS TC (NCT01218776).
  8. Create an ISACS ARCHIVES Library, linking a result from a publication, pipeline, or discovery of the data sent to ISACS ARCHIVES to its records for publications of results.

Policy Implementation ISACS ARCHIVES expects investigators and their institutions to provide basic plans for policy implementation

At present PI Study Investigators:

  • ISACS TC. International Survey of Acute Coronary Syndromes in Transitional Countries (ClinicalTrials.gov Identifier NCT01218776) from October 2010 to present. Contact person: Raffaele Bugiardini, MD University of Bologna email raffaele.bugiardini@unibo.it
  • HORACS: hospital registry for acute coronary syndrome in Serbia from January 2002 to September 2010. Contact person: Zorana Vasiljevic, MD Medical Faculty, University of Belgrade, email zoranav@eunet.rs
  • EMMACE-3 X. Long-term Follow-up of Health-Related Quality of Life in Patients With Acute Coronary Syndrome (ClinicalTrials.gov Identifier NCT01955525) during the period of 2011 to 2013. Contact person: Chris P Gale University of Leeds email c.p.gale@leeds.ac.uk

ISACS ARCHIVES Data Access Committee

  • Raffaele Bugiardini, University of Bologna (Principal Investigator)
  • Chris P Gale, University of Leeds
  • Olivia Manfrini, University of Bologna
  • Lina Badimon, Cardiovascular Research Institute (ICCC), CiberCV-Institute Carlos III, IIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona
  • Mihaela van der Schaar, University of Cambridge

ISACS ARCHIVES Data Sharing Coordinators

  • Edina Cenko University of Bologna
  • Jinsung Yoon, Department of Electrical and Computer Engineering, University of California, Los Angeles

Sponsor University of Bologna

Inquiries

Please direct all inquiries to:

Principal Investigator: Raffaele Bugiardini, MD University of Bologna

Being tested
Non-interventional patient registry
Medical subject headings
Acute Coronary Syndrome, Angina, Unstable, Myocardial Infarction, Coronary Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-interventional patient registryOther

    Non-interventional patient registry

Study groups in NCT04008173
Study groupRoleWhat they receive
MaleNon-interventional patient registry
Receives: Other: Non-interventional patient registry
FemaleNon-interventional patient registry
Receives: Other: Non-interventional patient registry
Kidney DiseaseNon-interventional patient registry
Receives: Other: Non-interventional patient registry
DiabetesNon-interventional patient registry
Receives: Other: Non-interventional patient registry
ElderlyNon-interventional patient registry
Receives: Other: Non-interventional patient registry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. All causes death

    All causes death

    Measured: 30 days

  2. All causes death

    All causes death

    Measured: 6 months

  3. All causes death

    All causes death

    Measured: 1 year

Secondary outcomes (4)
  1. Cardiovascular death

    Cardiovascular death

    Measured: up to 1 year

  2. Recurrent myocardial infarction

    A disorder characterized by signs and symptoms related to acute ischemia of the myocardium secondary to coronary artery disease

    Measured: up to 1 year

  3. Pharmacogenomics

    DNA sequence data to predict drug response and to inform drug discovery and development

    Measured: up to 1 year

  4. Cardiovascular genetics of coronary heart disease

    Common variant genotyping for risk prediction

    Measured: up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2019
  2. Study start28 Jun 2019
  3. Primary completion31 Dec 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
130,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04008173
Sponsor's protocol ID
University of Bologna
Acronym
ISACS-ARCHIVES
Status last verified
Apr 2026
First submitted
28 Jun 2019
Last updated
1 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Bugiardini R, Yoon J, Kedev S, Stankovic G, Vasiljevic Z, Milicic D, Manfrini O, van der Schaar M, Gale CP, Badimon L, Cenko E. Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease. Hypertension. 2020 Sep;76(3):819-826. doi: 10.1161/HYPERTENSIONAHA.120.15323. Epub 2020 Jul 13.

    PubMed 32654558
  • Bugiardini R, Cenko E, Yoon J, van der Schaar M, Kedev S, Gale CP, Vasiljevic Z, Bergami M, Milicic D, Zdravkovic M, Krljanac G, Badimon L, Manfrini O. Concerns about the use of digoxin in acute coronary syndromes. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):474-482. doi: 10.1093/ehjcvp/pvab055.

    PubMed 34251454
  • Vasiljevic Z, Scarpone M, Bergami M, Yoon J, van der Schaar M, Krljanac G, Asanin M, Davidovic G, Simovic S, Manfrini O, Mickovski-Katalina N, Badimon L, Cenko E, Bugiardini R. Smoking and sex differences in first manifestation of cardiovascular disease. Atherosclerosis. 2021 Aug;330:43-51. doi: 10.1016/j.atherosclerosis.2021.06.909. Epub 2021 Jun 26.

    PubMed 34233252
  • Bugiardini R, Yoon J, Mendieta G, Kedev S, Zdravkovic M, Vasiljevic Z, Milicic D, Manfrini O, van der Schaar M, Gale CP, Bergami M, Badimon L, Cenko E. Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome. J Am Coll Cardiol. 2022 May 24;79(20):2021-2033. doi: 10.1016/j.jacc.2022.03.354.

    PubMed 35589164

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Coronary Syndrome and Unstable Angina Pectoris, run by University of Bologna at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

All causes death (time frame: 30 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04008173, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in